Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum A Delphi Consensus of International Experts

被引:292
作者
Maverakis, Emanual [1 ]
Ma, Chelsea [1 ]
Shinkai, Kanade [2 ]
Fiorentino, David [3 ,4 ]
Callen, Jeffrey P. [5 ]
Wollina, Uwe [6 ]
Marzano, Angelo Valerio [7 ]
Wallach, Daniel [8 ]
Kim, Kyoungmi [9 ]
Schadt, Courtney [5 ]
Ormerod, Anthony [10 ]
Fung, Maxwell A. [1 ]
Steel, Andrea [1 ]
Patel, Forum [1 ]
Qin, Rosie [1 ]
Craig, Fiona [10 ]
Williams, Hywel C. [11 ]
Powell, Frank [12 ]
Merleev, Alexander [1 ]
Cheng, Michelle Y. [1 ]
机构
[1] Univ Calif Davis, Dept Dermatol, 3301 C St,Ste1400, Sacramento, CA 95816 USA
[2] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
[3] Stanford Univ, Dept Dermatol, Div Rheumatol & Immunol, Stanford, CA 94305 USA
[4] Stanford Univ, Div Rheumatol & Immunol, Dept Internal Med, Stanford, CA 94305 USA
[5] Univ Louisville, Dept Med, Div Dermatol, Louisville, KY 40292 USA
[6] Acad Teaching Hosp Dresden, Dept Dermatol & Allergol, Dresden, Germany
[7] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Milano Dipartimento Fisiopatol Med Chirurg & Trap, UOC Dermatol, Milan, Italy
[8] Paris Hosp, Dept Dermatol, Paris, France
[9] Univ Calif Davis, Div Biostat, Dept Publ Hlth Sci, Davis, CA 95616 USA
[10] Univ Aberdeen, Dept Dermatol, Sch Med & Dent, Aberdeen, Scotland
[11] Univ Nottingham, Ctr Evidence Based Dermatol, Kings Meadow Campus, Nottingham, England
[12] Univ Coll Dublin, Charles Inst Dermatol, Dublin, Ireland
基金
美国国家卫生研究院;
关键词
CUTANEOUS CRYPTOCOCCOSIS; SYSTEMIC ABSORPTION; MTHFR POLYMORPHISM; TOPICAL TACROLIMUS; PATIENT; INFLIXIMAB; ASSOCIATION; ADALIMUMAB; MANAGEMENT; CYTOKINES;
D O I
10.1001/jamadermatol.2017.5980
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
IMPORTANCE Pyoderma gangrenosum is a rare inflammatory skin condition that is difficult to diagnose. Currently, it is a "diagnosis of exclusion," a definition not compatible with clinical decision making or inclusion for clinical trials. OBJECTIVE To propose and validate diagnostic criteria for ulcerative pyoderma gangrenosum. EVIDENCE REVIEW Diagnostic criteria were created following a Delphi consensus exercise using the RAND/UCLA Appropriateness Method. The criteria were validated against peer-reviewed established cases of pyoderma gangrenosum and mimickers using k-fold cross-validation with methods of multiple imputation. FINDINGS Delphi exercise yielded 1 major criterion biopsy of ulcer edge demonstrating neutrophilic infiltrate and 8 minor criteria: (1) exclusion of infection; (2) pathergy; (3) history of inflammatory bowel disease or inflammatory arthritis; (4) history of papule, pustule, or vesicle ulcerating within 4 days of appearing; (5) peripheral erythema, undermining border, and tenderness at ulceration site; (6) multiple ulcerations, at least 1 on an anterior lower leg; (7) cribriform or "wrinkled paper" scar(s) at healed ulcer sites; and (8) decreased ulcer size within 1 month of initiating immunosuppressive medication(s). Receiver operating characteristic analysis revealed that 4 of 8 minor criteria maximized discrimination, yielding sensitivity and specificity of 86% and 90%, respectively. CONCLUSIONS AND RELEVANCE. This Delphi exercise produced 1 major criterion and 8 minor criteria for the diagnosis of ulcerative pyoderma gangrenosum. The criteria may serve as a guideline for clinicians, allowing for fewer misdiagnoses and improved patient selection for clinical trials.
引用
收藏
页码:461 / 466
页数:6
相关论文
共 50 条
  • [1] A Case of Pyoderma Gangrenosum in a Patient with Rheumatoid Arthritis Treated with Abatacept
    Akahoshi-Ikeda, Maki
    Yoshizawa, Seiji
    Motoshita, Junichi
    Fume, Masutaka
    Takeuchi, Satoshi
    [J]. ACTA DERMATO-VENEREOLOGICA, 2016, 96 (06) : 822 - 823
  • [2] Diagnostic criteria for pyoderma gangrenosum: results of a survey among dermatologic wound experts in Germany
    Al Ghazal, Philipp
    Klode, Joachim
    Dissemond, Joachim
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 (12): : 1129 - 1131
  • [3] Refractory pyoderma gangrenosum treated with platelet-rich plasma
    Alvarez-Lopez, M. A.
    Buron-Alvarez, I.
    Villegas-Fernandez, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (08) : 1423 - 1424
  • [4] Asahina A, 2006, ACTA DERM-VENEREOL, V86, P84
  • [5] Pyoderma gangrenosum in pregnancy
    Aytekin, S
    Tarlan, N
    Kalkanli, N
    Yaldiz, M
    Ünlü, G
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2002, 16 (05) : 546 - 548
  • [6] Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%
    Bellini, V.
    Simonetti, S.
    Lisi, P.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (01) : 113 - 115
  • [7] Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients
    Binus, A. M.
    Qureshi, A. A.
    Li, V. W.
    Winterfield, L. S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) : 1244 - 1250
  • [8] Familial pyoderma gangrenosum in association with common variable immunodeficiency
    Boussofara, L.
    Gammoudi, R.
    Ghariani, N.
    Aounallah, A.
    Sriha, B.
    Denguezli, M.
    Belajouza, C.
    Nouira, R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (04) : 944 - 946
  • [9] Brocq L, 1908, Bull. Soc med. Hop. Paris 3eme serie, V25, P290
  • [10] Pyoderma (echthyma) gangrenosum - Clinical and experimental observations in five cases occurring in adults
    Brunsting, LA
    Goeckerman, WH
    O'Leary, PA
    [J]. ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1930, 22 (04): : 655 - 680